Literature DB >> 18503201

Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. I: taxonomy, fermentation, isolation and biological properties.

Masato Iwatsuki1, Ryuji Uchida, Hitomi Yoshijima, Hideaki Ui, Kazuro Shiomi, Atsuko Matsumoto, Yoko Takahashi, Akio Abe, Hiroshi Tomoda, Satoshi Omura.   

Abstract

Enteropathogenic Escherichia coli (EPEC) expressing the Type III secretion system (TTSS) induced hemolysis of sheep blood cells. Using this assay, six structurally related compounds designated as guadinomines were isolated as inhibitors of TTSS-induced hemolysis by ion exchange column chromatography and HPLC from the culture broth of Streptomyces sp. K01-0509. Guadinomines A and B showed potent inhibition with IC50 values of 0.02 and 0.007 microg/ml, respectively, guadinomine D showed moderate activity (IC50: 8.5 microg/ml), while guadinomines C1 and C2 and guadinomic acid had no activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18503201     DOI: 10.1038/ja.2008.32

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  17 in total

Review 1.  Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds.

Authors:  Christopher T Walsh; Robert V O'Brien; Chaitan Khosla
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-31       Impact factor: 15.336

2.  Total Synthesis of (+)-Guadinomic Acid via Hydroxyl-Directed Guanidylation.

Authors:  Bradley T Reid; Artur K Mailyan; Armen Zakarian
Journal:  J Org Chem       Date:  2018-06-22       Impact factor: 4.354

Review 3.  Chemical inhibitors of the type three secretion system: disarming bacterial pathogens.

Authors:  Miles C Duncan; Roger G Linington; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

4.  New aliphatic acid amides from Streptomyces maoxianensis sp. nov.

Authors:  Jin-Meng Li; Kai Yan; Hui Zhang; Huan Qi; Ji Zhang; Wen-Sheng Xiang; Ji-Dong Wang; Xiang-Jing Wang
Journal:  J Antibiot (Tokyo)       Date:  2016-07-27       Impact factor: 2.649

5.  Cinatrins D and E, and virgaricin B, three novel compounds produced by a fungus, Virgaria boninensis FKI-4958.

Authors:  Takahiro Ishii; Kenichi Nonaka; Akihiro Sugawara; Masato Iwatsuki; Rokuro Masuma; Tomoyasu Hirose; Toshiaki Sunazuka; Satoshi Ōmura; Kazuro Shiomi
Journal:  J Antibiot (Tokyo)       Date:  2015-04-22       Impact factor: 2.649

6.  Molecular insights into the biosynthesis of guadinomine: a type III secretion system inhibitor.

Authors:  Tracy C Holmes; Aaron E May; Kathia Zaleta-Rivera; J Graham Ruby; Peter Skewes-Cox; Michael A Fischbach; Joseph L DeRisi; Masato Iwatsuki; Satoshi Ōmura; Chaitan Khosla
Journal:  J Am Chem Soc       Date:  2012-10-10       Impact factor: 15.419

7.  An NF-κB-based high-throughput screen identifies piericidins as inhibitors of the Yersinia pseudotuberculosis type III secretion system.

Authors:  Miles C Duncan; Weng Ruh Wong; Allison J Dupzyk; Walter M Bray; Roger G Linington; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

8.  Small molecules aimed at type III secretion systems to inhibit bacterial virulence.

Authors:  Lun K Tsou; Paul D Dossa; Howard C Hang
Journal:  Medchemcomm       Date:  2013-01-01       Impact factor: 3.597

9.  Small-molecule type III secretion system inhibitors block assembly of the Shigella type III secreton.

Authors:  Andreas K J Veenendaal; Charlotta Sundin; Ariel J Blocker
Journal:  J Bacteriol       Date:  2008-11-07       Impact factor: 3.490

10.  Isolation of Salmonella mutants resistant to the inhibitory effect of Salicylidene acylhydrazides on flagella-mediated motility.

Authors:  Isabel Martinez-Argudo; Andreas K J Veenendaal; Xia Liu; A Dorothea Roehrich; Maria C Ronessen; Giulia Franzoni; Katerine N van Rietschoten; Yusuke V Morimoto; Yumiko Saijo-Hamano; Matthew B Avison; David J Studholme; Keiichi Namba; Tohru Minamino; Ariel J Blocker
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.